Teva Pharmaceuticals allegedly made payments to Michael Reinstein, a Chicago physician, in return for prescribing generic clozapine, an anti-psychotic medication, to thousands or Medicare and Medicaid patients.
The alleged scheme resulted in the submission of more than 100,000 false claims to Illinois Medicaid and Medicare Part D.
“Teva Pharmaceuticals pushed its drug onto thousands of vulnerable patients without regard to their health and at the expense of the state Medicaid program and Illinois taxpayers,” said Madigan.
Under the settlement terms, Teva must pay the federal government close to $15.5 million and the state of Illinois more than $12.1 million, plus interest.
More Articles on False Claims Act:
Halifax to Institute Internal Monitoring as Part of $85M Settlement
West Virginia False Claims Act Dies In House
Case Expanding False Claims Act Exposure May Be Reviewed by Supreme Court
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
